Quantcast

Latest Retinoids Stories

2009-01-20 09:36:47

Patients using a cream containing tretinoin, a retinoid commonly used to treat acne and other conditions, appeared more likely to die than those using a placebo in a clinical trial that was halted early as a result, according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives journals. However, evidence does not suggest these excess deaths were caused by the therapy."The potential of retinoid compounds to prevent cutaneous malignant lesions [skin cancers]...

2009-01-20 08:53:43

Patients who use creams with an ingredient commonly used to treat acne are more likely to die than those who don't, a new study reveals. The Veterans Affairs Topical Tretinoin Chemoprevention (VATTC) Trial began in 1998 to test whether high-dose therapy with a cream containing the retinoid tretinoin, could prevent cancer. 1,131 veterans, mostly men over age 70, were randomly assigned to apply either a cream containing 0.1 percent tretinoin or an unmedicated cream daily to their face and ears....

2009-01-06 08:30:00

Epiduo(TM) Gel Combines Retinoid and Benzoyl Peroxide in a Single Product; Performs Better than Either Component Alone FORT WORTH, Texas, Jan. 6 /PRNewswire/ -- Galderma Laboratories, L.P. today announced the availability of Epiduo(TM) (adapalene and benzoyl peroxide) Gel 0.1% / 2.5%, the first and only, once-daily, topical acne treatment that combines the well-tolerated retinoid adapalene, and benzoyl peroxide, a well-known antimicrobial with no evidence of promoting bacterial resistance....

2008-10-21 03:00:19

Basel, Switzerland, October 21, 2008 - Basilea Pharmaceutica Ltd. announces that Toctino(R) (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has been approved by the French Health Products Safety Agency (Agence Francaise de Securite Sanitaire des Produits de Sante [AFSSAPS]). Following the recommendation for regulatory approval under the European decentralized procedure, Toctino(R) has received...

2008-10-15 03:00:22

Basilea Pharmaceutica Ltd. announces that Toctino(R) (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has been approved by Finland's National Agency for Medicines (NAM). Following the recommendation for regulatory approval under the European decentralized procedure, Toctino(R) received national regulatory approval in Finland. Following the regulatory approval of Toctino(R) in Finland, Basilea...

2008-10-06 03:00:29

Basel, Switzerland, October 6, 2008 - Basilea Pharmaceutica Ltd. announces that Toctino(R) (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has been approved by the German health authority "Bundesinstitut fuer Arzneimittel und Medizinprodukte" (BfArM). Following the recommendation for regulatory approval under the European decentralized procedure, Toctino(R) received national regulatory approval...

2008-09-22 03:00:30

Basilea Pharmaceutica Ltd. announces that Toctino(R) (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has been approved by the Danish Medicines Agency (DKMA). Following the recommendation for regulatory approval under the European decentralized procedure, Toctino(R) received national regulatory approval in Denmark. Marketing applications for the use of alitretinoin in the treatment of severe...

2008-09-08 03:00:25

Basel, Switzerland, September 8, 2008 - Basilea Pharmaceutica Ltd. announces that Toctino(R) (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom. Following the recommendation for regulatory approval under the European decentralized procedure, Toctino(R) received its first national regulatory...

2008-08-20 12:00:15

LOS ANGELES, Aug. 20 /PRNewswire/ -- Retin-A Micro(R) PUMP has teamed up with the popular teenage Web site ELLEgirl.com to send four contest winners later this summer to a weeklong My Beauty Camp in Santa Monica, California. With the new school year approaching, the goal of the camp is to empower girls to become successful women by helping them build confidence and boost self-esteem through all aspects of their academic and personal lives. One critical aspect of a teenager's...

2008-07-31 03:00:43

Basel, Switzerland, July 31, 2008 - Basilea Pharmaceutica Ltd. announces that Toctino(R) (alitretinoin), a new oral therapy for severe refractory Chronic Hand Eczema (CHE), was recommended for regulatory approval under the European decentralized procedure and will become the first authorized treatment for this chronic disabling disease. The concerned EU Member States concluded that the profile of Toctino(R) (alitretinoin) is favorable for the use in adults who suffer from severe CHE that is...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related